Cargando…
Predictive Markers of First Line Pazopanib Treatment in Kidney Cancer
Real-world evidence from clinical practices is fundamental for understanding the efficacy and tolerability of medicinal products. Patients with renal cell cancer were studied to gain data not represented by analyses conducted on highly selected patients participating in clinical trials. Our goal was...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Netherlands
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471165/ https://www.ncbi.nlm.nih.gov/pubmed/32572819 http://dx.doi.org/10.1007/s12253-020-00853-9 |